Connect with us

Hi, what are you looking for?

top
Europeans could begin receiving the Pfizer-BioNTech vaccine 'before the end of 2020', the companies said

Capital Health

UK approves Pfizer-BioNTech vaccine for rollout from ‘next week’

London, United Kingdom, Dec 2 – Britain on Wednesday became the first Western country to approve a Covid-19 vaccine for general use as it announced a rollout of Pfizer-BioNTech’s drug from next week. 

“The government has today accepted the recommendation from the independent Medicines and Healthcare products Regulatory Agency (MHRA) to approve Pfizer-BioNTech’s Covid-19 vaccine for use,” the department of health said in a statement.

“The vaccine will be made available across the UK from next week,” the statement said. Priority groups will include care home residents, health and care staff, the elderly and the clinically extremely vulnerable.

After months of “rigorous” clinical trials and thorough analysis of the data, the MHRA “concluded that the vaccine has met its strict standards of safety, quality and effectiveness”, the statement added.

“To aid the success of the vaccination programme it is vital everyone continues to play their part and abide by the necessary restrictions in their area so we can further suppress the virus and allow the NHS (National Health Service) to do its work without being overwhelmed.”

Pfizer chairman Albert Bourla said it was a “historic moment in the fight against Covid-19”. 

“This authorisation is a goal we have been working toward since we first declared that science will win, and we applaud the MHRA for their ability to conduct a careful assessment and take timely action to help protect the people of the UK,” he said.

Pfizer and BioNTech added that they expected further regulatory decisions from other countries “in the coming days and weeks”.

Advertisement. Scroll to continue reading.

The announcement came as England exited a month-long coronavirus lockdown, but most of the country remained under restrictions as a new regional system for cutting infection rates kicked in.

The four-week lockdown, which began in November, was imposed to stop surging rates of infection, ease pressure on health services, and to allow families to gather for Christmas.

Prime Minister Boris Johnson, a Covid survivor, succeeded in winning a vote on the measures in parliament late Tuesday, despite significant opposition within his own Conservative ranks.

“All we need to do now is to hold our nerve until these vaccines are indeed in our grasp and indeed being injected into our arms,” he told lawmakers before the vote.

Until then “we cannot afford to relax, especially during the cold months of winter”, he warned.

Comments
Advertisement

More on Capital News

World

Mexico City (AFP), May 17 – More than 100,000 people are now listed as missing in violence-wracked Mexico — a grim milestone that the...

NATIONAL NEWS

The copyright board stated that despite the Azimio coalition having a public performance license allowing it to play both local and international music, the...

August Elections

NYERI, Kenya, May 17 – Deputy President William Ruto says his running mate Rigathi Gachagua earned the position because he has a strong personality....

Top stories

NAIROBI, Kenya May 18 – The ICTA Authority has today signed a Memorandum of Understanding with education technologies firm Kodris Africa that will see...

August Elections

NAIROBI, Kenya May 17 – The number of nomination disputes within political parties has significantly reduced this year as compared to last year, Registrar...

Kenya

Nairobi, Kenya, May 17- George Wajackoyah, the Roots party presidential candidate has threatened to reintroduce the death penalty in the country to curb endemic...

Supreme Court

The exercise was overseen by IEBC Returning Officer Abdidahir Maalim Abdi who certified that Justice Ibrahim was the only person who stood validly nominated...

August Elections

NYERI, Kenya, May 17 – Deputy President William Ruto’s running mate Rigathi Gachagua has assured him that he will never betray him. Speaking during...